Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 1.58 B1.54 B1.59 B1.66 B1.61 B1.72 B 6.63 B Research & development —————— — Operating income 665 M410 M606 M925 M612 M893 M 3.2 B Non-Operating Income, Total 5 M8 M-3 M-3 M-7 M5 M -18 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 5 M8 M-3 M-3 M-7 M5 M -18 M Unusual income/expense —————— — Pretax income 624 M370 M557 M872 M560 M846 M 2.99 B Equity in earnings —————— — Taxes 154 M94 M147 M172 M146 M180 M 640 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 470 M276 M410 M700 M414 M666 M 2.35 B Discontinued operations —————— — Net income 470 M276 M410 M700 M414 M666 M 2.35 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 470 M276 M410 M700 M414 M666 M 2.35 B Basic earnings per share (Basic EPS) 2.341.382.073.542.133.44 12.02 Diluted earnings per share (Diluted EPS) 2.341.382.073.532.133.43 11.99 Average basic shares outstanding 200.8 M199.6 M198.3 M198.9 M194.6 M193.7 M — Diluted shares outstanding 201.3 M199.8 M198.5 M199.2 M194.8 M194 M — EBITDA 741 M485 M710 M1.02 B697 M979 M 3.54 B EBIT 651 M393 M616 M921 M600 M880 M 3.16 B Cost of revenue 5.43 B4.83 B5.26 B5.8 B5.15 B6.04 B 22.66 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 90 M92 M94 M97 M97 M99 M 387 M